Erratum: Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery (The Journal of Thoracic and Cardiovascular Surgery (2010) 140(5) (1018–1027) (S0022522310008688) (10.1016/j.jtcvs.2010.08.002));Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 5, 2010, Pages 1018-1027

  Vaduganathan, Muthiah ^a   Stone, Neil J ^a   Lee, Richard ^a   McGee Jr , Edwin C ^a   Malaisrie, S Chris ^a   Silverberg, Robert A ^a   McCarthy, Patrick M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART SURGERY; HEART VALVE SURGERY; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION; HEART VALVE DISEASES; HYPERLIPIDEMIAS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHICAGO; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART VALVE DISEASES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77958001966     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.06.037     Document Type: Erratum

References (25)

1. J.L. Goldstein, and M.S. Brown The LDL receptor Arterioscler Thromb Vasc Biol 29 2009 431 438
2. E.J. Mills, B. Rachlis, P. Wu, P.J. Devereaux, P. Arora, and D. Perri Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients J Am Coll Cardiol 52 2008 1769 1781
3. T.J. Wilt, H.E. Bloomfield, R. MacDonald, D. Nelson, I. Rutks, and M. Ho Effectiveness of statin therapy in adults with coronary heart disease Arch Intern Med 164 2004 1427 1436
4. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, and D.B. Hunninghake Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
5. O.J. Liakopoulos, Y.H. Choi, P.L. Haldenwang, J. Strauch, T. Wittwer, and H. Dorge Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients Eur Heart J 29 2008 1548 1559
6. M. Thielmann, M. Neuhauser, A. Marr, B.R. Jaeger, D. Wendt, and B. Schuetze Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery J Thorac Cardiovasc Surg 134 2007 1143 1149
7. J.M. Martinez-Comendador, J.R. Alvarez, I. Mosquera, J. Sierra, B. Adrio, and J.G. Carro Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery Eur J Cardiothorac Surg 36 2009 998 1005
8. C. Morgan, M. Zappitelli, and P. Gill Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: A systematic review Crit Care 13 2009 R165
9. H.L. Lazar, Y. Bao, Y. Zhang, and S.A. Bernard Pretreatment with statins enhances myocardial protection during coronary revascularization J Thorac Cardiovasc Surg 125 2003 1037 1042
10. V.A. Mannacio, D. Iorio, V. De Amicis, F. Di Lello, and F. Musumeci Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: A randomized trial J Thorac Cardiovasc Surg 136 2008 1541 1548
11. M.A. Albert, E. Danielson, N. Rifai, and P.M. Ridker Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study JAMA 286 2001 64 70
12. P.M. Ridker, N. Rifai, M.A. Pfeffer, F. Sacks, E. Braunwald The Cholesterol and Recurrent Events (CARE) Investigators Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 1999 230 235
13. J.K. Pai, T. Pischon, J. Ma, J.E. Manson, S.E. Hankinson, and K. Joshipura Inflammatory markers and the risk of coronary heart disease in men and women N Engl J Med 351 2004 2599 2610 (Pubitemid 39628581)
14. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843 (Pubitemid 30165206)
15. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
16. J. Davignon Beneficial cardiovascular pleiotropic effects of statins Circulation 109 23 Suppl. 1 2004 III39 III43
17. J.K. Liao Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol Am J Cardiol 96 2005 24F 33F
18. M. Tabata, Z. Khalpey, L.H. Cohn, F.Y. Chen, R.M. Bolman III, and J.D. Rawn Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery J Thorac Cardiovasc Surg 136 2008 1510 1513
19. L.M. Fedoruk, H. Wang, M.R. Conaway, I.L. Kron, and K.C. Johnston Statin therapy improves outcomes after valvular heart surgery Ann Thorac Surg 85 2008 1521 1526
20. N.J. Stone Stopping statins Circulation 110 2004 2280 2282
21. W.B. Kannel, T.R. Dawber, A. Kagan, N. Revotskie, and J. Stokes III Factors of risk in the development of coronary heart disease - Six year follow-up experience: The Framingham study Ann Intern Med 55 1961 33 50
22. H. Takagi, N. Kawai, and T. Umemoto Preoperative statin therapy reduces postoperative all-cause mortality in cardiac surgery: A meta-analysis of controlled studies J Thorac Cardiovasc Surg 137 2009 e52 e53
23. M. Czerny, H. Baumer, J. Kilo, A. Lassnigg, A. Hamwi, and T. Vukovich Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass Eur J Cardiothorac Surg 17 2000 737 742
24. S. Wan, and A.P. Yim Cytokines in myocardial injury: Impact on cardiac surgical approach Eur J Cardiothorac Surg 16 Suppl 1 1999 S107 S111
25. A. Kulik, R. Levin, M. Ruel, T.G. Mesana, D.H. Solomon, and N.K. Choudhry Patterns and predictors of statin use after coronary artery bypass graft surgery J Thorac Cardiovasc Surg 134 2007 932 938